David S. Ege
CIK 1829360 · View on SEC EDGAR ↗
First SEC filing: Oct. 21, 2020 · Latest: Oct. 21, 2020
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 16, 2024 | MCRB | S 10b5-1 | 1,128 | $0.84 | $948 | 77,575 Direct | -1.43% | Disposed | -73.5% (price as of 2026-08-18) |
| May 15, 2024 | MCRB | S 10b5-1 | 1,090 | $0.94 | $1,025 | 75,734 Direct | -1.42% | Disposed | -76.3% (price as of 2026-08-18) |
| Feb. 16, 2024 | MCRB | S 10b5-1 | 5,010 | $1.08 | $5,411 | 73,856 Direct | -6.35% | Disposed | -79.4% (price as of 2026-08-18) |
| Oct. 30, 2023 | MCRB | S 10b5-1 | 4,066 | $1.35 | $5,489 | 66,991 Direct | -5.72% | Disposed | -83.5% (price as of 2026-08-18) |
| April 28, 2023 | MCRB | S 10b5-1 | 7,038 | $5.19 | $36,527 | 59,696 Direct | -10.55% | Disposed | -95.7% (price as of 2026-08-18) |
| Oct. 31, 2022 | MCRB | S 10b5-1 | 5,012 | $7.93 | $39,745 | 46,734 Direct | -9.69% | Disposed | -97.2% (price as of 2026-08-18) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 15, 2024 | MCRB | Restricted Stock Units | Common Stock (2,969) | — | — | 2,969 | Disposed |
| May 15, 2024 | MCRB | Restricted Stock Units | Common Stock (2,968) | — | — | 2,968 | Disposed |
| Feb. 15, 2024 | MCRB | Restricted Stock Units | Common Stock (11,875) | — | — | 11,875 | Disposed |
| Feb. 14, 2024 | MCRB | Restricted Stock Units | Common Stock (31,250) | — | — | 31,250 | Acquired |
| Feb. 14, 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (287,905) | $1.10 | Feb. 13, 2034 | 287,905 | Acquired |
| Feb. 14, 2024 | MCRB | Stock Option (Right to Buy) | Common Stock (187,500) | $1.10 | Feb. 13, 2034 | 187,500 | Acquired |
| Oct. 27, 2023 | MCRB | Restricted Stock Units | Common Stock (11,361) | — | — | 11,361 | Disposed |
| April 27, 2023 | MCRB | Restricted Stock Units | Common Stock (22,721) | — | — | 22,721 | Acquired |
| Feb. 3, 2023 | MCRB | Stock Option (Right to Buy) | Common Stock (95,000) | $5.50 | Feb. 2, 2033 | 95,000 | Acquired |
| Feb. 3, 2023 | MCRB | Restricted Stock Units | Common Stock (47,500) | — | — | 47,500 | Acquired |
| Feb. 4, 2022 | MCRB | Stock Option (Right to Buy) | Common Stock (175,000) | $7.38 | Feb. 3, 2032 | 175,000 | Acquired |
| Oct. 19, 2020 | MCRB | Stock Option (Right to Buy) | Common Stock (200,000) | $32.60 | Oct. 18, 2030 | 200,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $76,923 | $65,000 | — | — | — | — | $785 | $5,318,587 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.